Early Detection of Pulmonary Hypertension in Connective Tissue Disease = Early Detection of Pulmonary Hypertension in Connective Tissue Disease

참고문헌 (Reference)

1 Hachulla E, "detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study" 52 : 3792-3800, 2005

2 Becker MO, "Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis" 190 : 808-817, 2014

3 Affandi AJ, "Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment" 37 : 475-487, 2015

4 Hoeper MM, "The changing landscape of pulmonary arterial hypertension and implications for patient care" 23 : 450-457, 2014

5 Lefèvre G, "Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis" 65 : 2412-2423, 2013

6 Morrisroe K, "Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study" 16 : 134-, 2016

7 Iudici M, "Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort" 31 (31): 31-36, 2013

8 Aithala R, "Pulmonary hypertension in connective tissue diseases: an update" 20 : 5-24, 2017

9 Hoeper MM, "Pulmonary hypertension due to chronic lung disease: updated recommendations of the Cologne consensus conference 2011" 154 (154): S45-S53, 2011

10 Ju-Yang Jung, "Pulmonary Hypertension in Connective Tissue Disease is Associated with the New York Heart Association Functional Class and Forced Vital Capacity, But Not with Interstitial Lung Disease" 대한류마티스학회 25 (25): 179-187, 2018

11 Hinchcliff M, "Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population" 38 : 2172-2179, 2011

12 Avouac J, "Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies" 37 : 2290-2298, 2010

13 Steen V, "Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement" 48 : 516-522, 2003

14 Benza RL, "Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)" 122 : 164-172, 2010

15 Thakkar V, "N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study" 14 : R143-, 2012

16 Michelfelder M, "Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity" 36 : 381-390, 2017

17 Goh NS, "Interstitial lung disease in systemic sclerosis: a simple staging system" 177 : 1248-1254, 2008

18 Bussone G, "Interstitial lung disease in systemic sclerosis" 10 : 248-255, 2011

19 Allanore Y, "High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis" 58 : 284-291, 2008

20 Coghlan JG, "Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study" 73 : 1340-1349, 2014

21 Bhatnagar A, "Evaluating suspected pulmonary hypertension: a structured approach" 85 : 468-480, 2018

22 Lau EM, "Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward" 32 : 2489-2498, 2011

23 Maron BA, "Diagnosis, treatment, and clinical management of pulmonary arterial hypertension in the contemporary era: a review" 1 : 1056-1065, 2016

24 Hsu VM, "Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study" 44 : 55-62, 2014

25 Hoeper MM, "Definitions and diagnosis of pulmonary hypertension" 62 (62): D42-D50, 2013

26 Thakkar V, "Connective tissue disease-related pulmonary arterial hypertension" 30 : 22-38, 2016

27 Condliffe R, "Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era" 179 : 151-157, 2009

28 Condliffe R, "Connective tissue disease- associated pulmonary arterial hypertension" 7 : 06-, 2015

29 Leuchte HH, "Clinical significance of brain natriuretic peptide in primary pulmonary hypertension" 43 : 764-770, 2004

30 Warwick G, "Biomarkers in pulmonary hypertension" 32 : 503-512, 2008

31 Odler B, "Biomarkers for pulmonary vascular remodeling in systemic sclerosis: a pathophysiological approach" 9 : 587-, 2018

32 Haddad RN, "An evidence-based approach to screening and diagnosis of pulmonary hypertension" 31 : 382-390, 2015

33 Thenappan T, "A USA-based registry for pulmonary arterial hypertension: 1982-2006" 30 : 1103-1110, 2007

34 Galiè N, "2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)" 37 : 67-119, 2016